NK Cell Combination Therapy in Lung Cancer: Raising Remission Rates from 16.7% to 75% and Achieving Complete Response in Select Patients — A New Hope from a Patient’s Perspective
Among all malignancies worldwide, lung cancer has held the top position in both incidence and mortality for more than a decade. For patients like me, this statistic isn’t just a number—it represents the silent, persistent threat that lung cancer poses to our health and survival. In China alone, lung cancer accounts for more than one-fifth of all new cancer cases and nearly one-third of cancer-related deaths. In practical terms, this means that in every four cancer deaths, one is due to lung cancer.









